Published in Exp Cell Res on December 10, 2004
Retracted Calreticulin inhibits commitment to adipocyte differentiation. J Cell Biol (2008) 0.93
Akt- and Foxo1-interacting WD-repeat-FYVE protein promotes adipogenesis. EMBO J (2008) 0.93
The Ca2+/calmodulin-dependent protein kinase kinase, CaMKK2, inhibits preadipocyte differentiation. Endocrinology (2011) 0.92
Gene expression profiles in Atlantic salmon adipose-derived stromo-vascular fraction during differentiation into adipocytes. BMC Genomics (2010) 0.84
Layer-shaped alginate hydrogels enhance the biological performance of human adipose-derived stem cells. BMC Biotechnol (2012) 0.82
The Ca(2+)/Calmodulin/CaMKK2 Axis: Nature's Metabolic CaMshaft. Trends Endocrinol Metab (2016) 0.79
Effect of Pulsed Electromagnetic Field on Bone Formation and Lipid Metabolism of Glucocorticoid-Induced Osteoporosis Rats through Canonical Wnt Signaling Pathway. Evid Based Complement Alternat Med (2016) 0.79
Receptors for NPY and PACAP differ in expression and activity during adipogenesis in the murine 3T3-L1 fibroblast cell line. Br J Pharmacol (2009) 0.79
Extracellular Calcium Modulates Chondrogenic and Osteogenic Differentiation of Human Adipose-Derived Stem Cells: A Novel Approach for Osteochondral Tissue Engineering Using a Single Stem Cell Source. Tissue Eng Part A (2015) 0.78
Inhibition of adipogenesis: a new job for the ER Ca2+ pool. J Cell Biol (2008) 0.77
A promoter-level mammalian expression atlas. Nature (2014) 6.25
Retracted Tunable plasmonic nanoprobes for theranostics of prostate cancer. Theranostics (2011) 1.73
Changes in gene expression during the early to mid-luteal (receptive phase) transition in human endometrium detected by high-density microarray screening. Mol Hum Reprod (2002) 1.71
beta2-microglobulin is a signaling and growth-promoting factor for human prostate cancer bone metastasis. Cancer Res (2006) 1.55
Hyaluronic acid-based hydrogels as 3D matrices for in vitro evaluation of chemotherapeutic drugs using poorly adherent prostate cancer cells. Biomaterials (2009) 1.37
Potential role for heparan sulfate proteoglycans in regulation of transforming growth factor-beta (TGF-beta) by modulating assembly of latent TGF-beta-binding protein-1. J Biol Chem (2007) 1.32
Modeling Ewing sarcoma tumors in vitro with 3D scaffolds. Proc Natl Acad Sci U S A (2013) 1.23
Modulation of differentiation and mineralization of marrow stromal cells cultured on biomimetic hydrogels modified with Arg-Gly-Asp containing peptides. J Biomed Mater Res A (2004) 1.22
Multifunctionality of extracellular and cell surface heparan sulfate proteoglycans. Cell Mol Life Sci (2009) 1.22
The in vivo performance of plasmonic nanobubbles as cell theranostic agents in zebrafish hosting prostate cancer xenografts. Biomaterials (2010) 1.18
Osteogenic differentiation of rat bone marrow stromal cells cultured on Arg-Gly-Asp modified hydrogels without dexamethasone and beta-glycerol phosphate. Biomaterials (2005) 1.17
Attachment, proliferation, and migration of marrow stromal osteoblasts cultured on biomimetic hydrogels modified with an osteopontin-derived peptide. Biomaterials (2004) 1.13
Hyaluronic Acid-Based Hydrogels: from a Natural Polysaccharide to Complex Networks. Soft Matter (2012) 1.12
Evaluation of cross-linking methods for electrospun gelatin on cell growth and viability. Biomacromolecules (2009) 1.10
Chondrogenic activity of the heparan sulfate proteoglycan perlecan maps to the N-terminal domain I. J Bone Miner Res (2002) 1.09
Chondrogenic differentiation on perlecan domain I, collagen II, and bone morphogenetic protein-2-based matrices. Tissue Eng (2006) 1.06
Perlecan domain I-conjugated, hyaluronic acid-based hydrogel particles for enhanced chondrogenic differentiation via BMP-2 release. Biomaterials (2009) 1.05
Perlecan knockdown in metastatic prostate cancer cells reduces heparin-binding growth factor responses in vitro and tumor growth in vivo. Clin Exp Metastasis (2005) 1.05
Association of the α(2)δ(1) subunit with Ca(v)3.2 enhances membrane expression and regulates mechanically induced ATP release in MLO-Y4 osteocytes. J Bone Miner Res (2011) 1.03
Novel surface expression of reticulocalbin 1 on bone endothelial cells and human prostate cancer cells is regulated by TNF-alpha. J Cell Biochem (2008) 1.02
Conditional disruption of calcineurin B1 in osteoblasts increases bone formation and reduces bone resorption. J Biol Chem (2007) 1.01
Nuclear translocation of the 1,25D3-MARRS (membrane associated rapid response to steroids) receptor protein and NFkappaB in differentiating NB4 leukemia cells. Exp Cell Res (2010) 1.00
Quantitative modeling and analysis of the transforming growth factor beta signaling pathway. Biophys J (2009) 1.00
Fiber diameters control osteoblastic cell migration and differentiation in electrospun gelatin. J Biomed Mater Res A (2010) 1.00
Hierarchically structured, hyaluronic acid-based hydrogel matrices via the covalent integration of microgels into macroscopic networks. Soft Matter (2010) 0.99
Perlecan/Hspg2 deficiency alters the pericellular space of the lacunocanalicular system surrounding osteocytic processes in cortical bone. J Bone Miner Res (2011) 0.98
Lumen formation in three-dimensional cultures of salivary acinar cells. Otolaryngol Head Neck Surg (2010) 0.98
Biofunctionalization of electrospun PCL-based scaffolds with perlecan domain IV peptide to create a 3-D pharmacokinetic cancer model. Biomaterials (2010) 0.96
Recreating the tumor microenvironment in a bilayer, hyaluronic acid hydrogel construct for the growth of prostate cancer spheroids. Biomaterials (2012) 0.96
Coating electrospun collagen and gelatin fibers with perlecan domain I for increased growth factor binding. Biomacromolecules (2007) 0.95
Improved cellular specificity of plasmonic nanobubbles versus nanoparticles in heterogeneous cell systems. PLoS One (2012) 0.94
Differentiation-induced loss of heparan sulfate in human exostosis derived chondrocytes. Differentiation (2005) 0.94
Interleukin-6: a bone marrow stromal cell paracrine signal that induces neuroendocrine differentiation and modulates autophagy in bone metastatic PCa cells. Autophagy (2012) 0.94
RANK- and c-Met-mediated signal network promotes prostate cancer metastatic colonization. Endocr Relat Cancer (2014) 0.93
Phosphorylated osteopontin promotes migration of human choriocarcinoma cells via a p70 S6 kinase-dependent pathway. J Cell Biochem (2005) 0.92
Implantable three-dimensional salivary spheroid assemblies demonstrate fluid and protein secretory responses to neurotransmitters. Tissue Eng Part A (2013) 0.92
Paracrine factors produced by bone marrow stromal cells induce apoptosis and neuroendocrine differentiation in prostate cancer cells. Prostate (2011) 0.92
Hypoxia increases VEGF-A production by prostate cancer and bone marrow stromal cells and initiates paracrine activation of bone marrow endothelial cells. Clin Exp Metastasis (2006) 0.91
Osteoprotegerin expression and secretion are regulated by calcium influx through the L-type voltage-sensitive calcium channel. Endocrinology (2003) 0.91
Ribosomal protein L29/HIP deficiency delays osteogenesis and increases fragility of adult bone in mice. J Orthop Res (2009) 0.91
Perlecan domain IV peptide stimulates salivary gland cell assembly in vitro. Tissue Eng Part A (2009) 0.90
Microfabricated electrospun collagen membranes for 3-D cancer models and drug screening applications. Biomacromolecules (2009) 0.90
Injectable perlecan domain 1-hyaluronan microgels potentiate the cartilage repair effect of BMP2 in a murine model of early osteoarthritis. Biomed Mater (2012) 0.89
HIP/RPL29 down-regulation accompanies terminal chondrocyte differentiation. Differentiation (2003) 0.89
Identification and characterization of 1,25D3-membrane-associated rapid response, steroid (1,25D3-MARRS) binding protein. J Steroid Biochem Mol Biol (2004) 0.89
Perlecan-containing pericellular matrix regulates solute transport and mechanosensing within the osteocyte lacunar-canalicular system. J Bone Miner Res (2014) 0.89
Expression of voltage sensitive calcium channel (VSCC) L-type Cav1.2 (alpha1C) and T-type Cav3.2 (alpha1H) subunits during mouse bone development. Dev Dyn (2005) 0.88
Coculture with prostate cancer cells alters endoglin expression and attenuates transforming growth factor-beta signaling in reactive bone marrow stromal cells. Mol Cancer Res (2007) 0.88
A novel in vivo model for evaluating functional restoration of a tissue-engineered salivary gland. Laryngoscope (2013) 0.85
A control engineering approach to understanding the TGF-β paradox in cancer. J R Soc Interface (2011) 0.85
Heparanase expression and function during early pregnancy in mice. Biol Reprod (2007) 0.84
Osteoblast Ca(2+) permeability and voltage-sensitive Ca(2+) channel expression is temporally regulated by 1,25-dihydroxyvitamin D(3). Am J Physiol Cell Physiol (2005) 0.84
Hyaluronan (HA) interacting proteins RHAMM and hyaluronidase impact prostate cancer cell behavior and invadopodia formation in 3D HA-based hydrogels. PLoS One (2012) 0.83
Hydrogel-based 3D model of patient-derived prostate xenograft tumors suitable for drug screening. Mol Pharm (2014) 0.83
p62/SQSTM1 is required for cell survival of apoptosis-resistant bone metastatic prostate cancer cell lines. Prostate (2013) 0.83
Amphiphilic block co-polyesters bearing pendant cyclic ketal groups as nanocarriers for controlled release of camptothecin. J Biomater Sci Polym Ed (2011) 0.82
HIP/RPL29 antagonizes VEGF and FGF2 stimulated angiogenesis by interfering with HS-dependent responses. J Cell Biochem (2008) 0.82
Tumor necrosis factor-α treatment of HepG2 cells mobilizes a cytoplasmic pool of ERp57/1,25D₃-MARRS to the nucleus. J Cell Biochem (2011) 0.81
Perlecan functions in chondrogenesis: insights from in vitro and in vivo models. Cells Tissues Organs (2004) 0.80
Ribozyme-mediated perlecan knockdown impairs chondrogenic differentiation of C3H10T1/2 fibroblasts. Differentiation (2006) 0.80
Transcriptional activation by NFκB increases perlecan/HSPG2 expression in the desmoplastic prostate tumor microenvironment. J Cell Biochem (2014) 0.80
A rapid and simple nonradioactive method for in vitro testing of ribozyme activity. Antisense Nucleic Acid Drug Dev (2002) 0.80
Deficiency in perlecan/HSPG2 during bone development enhances osteogenesis and decreases quality of adult bone in mice. Calcif Tissue Int (2014) 0.79
Rapamycin selectively reduces the association of transcripts containing complex 5' UTRs with ribosomes in C4-2B prostate cancer cells. J Cell Biochem (2009) 0.79
Dynamic interactions between L-type voltage-sensitive calcium channel Cav1.2 subunits and ahnak in osteoblastic cells. Am J Physiol Cell Physiol (2009) 0.79
Mining the extracellular matrix for tissue engineering applications. Regen Med (2010) 0.79
Involvement of 1,25D3-MARRS (membrane associated, rapid response steroid-binding), a novel vitamin D receptor, in growth inhibition of breast cancer cells. Exp Cell Res (2009) 0.79
Effect of HIP/ribosomal protein L29 deficiency on mineral properties of murine bones and teeth. Bone (2010) 0.79
Biomaterials-based strategies for salivary gland tissue regeneration. Biomater Sci (2016) 0.78
Structure-based design of selective agonists for a rickets-associated mutant of the vitamin d receptor. J Am Chem Soc (2002) 0.78
Mechanism of 24,25-dihydroxyvitamin D3-mediated inhibition of rapid, 1,25-dihydroxyvitamin D3-induced responses: role of reactive oxygen species. J Cell Biochem (2006) 0.78
Type I collagen-mediated changes in gene expression and function of prostate cancer cells. Cancer Treat Res (2004) 0.78
Spatiotemporal distribution of heparan sulfate epitopes during murine cartilage growth plate development. Histochem Cell Biol (2006) 0.78
Chaperone properties of pdia3 participate in rapid membrane actions of 1α,25-dihydroxyvitamin d3. Mol Endocrinol (2013) 0.78
Co-culture of osteocytes and neurons on a unique patterned surface. Biointerphases (2011) 0.77
Identification and characterization of 1,25D3-membrane-associated rapid response, steroid (1,25D3-MARRS)-binding protein in rat IEC-6 cells. Steroids (2005) 0.77
Ribozyme-mediated reduction of wild-type and mutant cartilage oligomeric matrix protein (COMP) mRNA and protein. RNA (2009) 0.77
Decidual heparanase activity is increased during pregnancy in the baboon (Papio anubis) and in in vitro decidualization of human stromal cells. Biol Reprod (2007) 0.77
Rainbow Plasmonic Nanobubbles: Synergistic Activation of Gold Nanoparticle Clusters. J Nanomed Nanotechnol (2011) 0.76
Regulation of expression of 1,25D3-MARRS/ERp57/PDIA3 in rat IEC-6 cells by TGF beta and 1,25(OH)2D3. Steroids (2006) 0.76
A new assay for functional screening of BRCA2 linker region mutations identifies variants that alter chemoresistance to cisplatin. Exp Cell Res (2011) 0.75
Retraction of "Tunable Plasmonic Nanoprobes for Theranostics of Prostate Cancer". Theranostics (2017) 0.75
Perlecan/HSPG2 and matrilysin/MMP-7 as indices of tissue invasion: tissue localization and circulating perlecan fragments in a cohort of 288 radical prostatectomy patients. Oncotarget (2016) 0.75